ERBB2 and breast cancer: To observe tumor development in response to BSp, GTPs and combination (BSp + GTPs) treatments, we evaluated the effects of these treatment approaches in Her2/neu transgenic mouse model that develops spontaneous ER(−) mammary tumors driven by overexpression of an oncogene.